VEGFA and wet macular degeneration: This study aimed to investigate the value and difference in predictive performance between ophthalmologists and a previously developed and validated artificial intelligence (AI) model, and to evaluate how AI assistance influences expert decision-making in reliably assessing recurrence prediction of neovascular age-related macular degeneration (nAMD) after anti-vascular endothelial growth factor (VEGF) treatment.